Delivery Order SPE2DR25D2100-SPE2DR26FA0MC
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Feraheme 510 mg/17 ml vials valued at $7,744.26 with firm fixed pricing. This non-set-aside competitive award is scheduled for completion by September 23, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $2,894.98 to AmerisourceBergen Drug Corp for the supply of Feraheme 510 mg/17 mL vials on December 10, 2025, with completion scheduled for December 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $2,262.01 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Feraheme 510 mg/17 ml vials. This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 28, 2025, with performance to be executed at the company's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Feraheme 510 mg/17 mL vials. This contract, valued at $1,777.74 with a firm fixed price structure, represents a non-set-aside competitive award with an ultimate completion date of May 21, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,382.64 to AmerisourceBergen Drug Corp for the supply of Feraheme 510 mg/17 mL vials. This competitively awarded, firm fixed-price contract has a completion date of November 21, 2025, and represents a non-set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Feraheme (ferumoxytol) 510 mg/17 mL vials valued at $18,525.38 under a firm fixed-price arrangement. The award, made on August 26, 2025, with an ultimate completion date of August 27, 2025, represents a competitive, non-set-aside procurement for pharmaceutical supply to support federal medical needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for the Defense...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on June 2, 2025, for the supply of Feraheme 510 mg/17 ml vials, with a ceiling value of $4,478.39. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of June 3, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- The Defense Logistics Agency's Medical Supply Chain issued a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Feraheme 510 mg/17 mL vials. This firm fixed-price contract, valued at $17,427.93, is a non-set-aside award representing a competitively awarded delivery order with an ultimate completion date of September 30, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Feraheme 510 mg/17 mL vials. This firm fixed-price delivery order, valued at $6,486.54, represents a non-competitive set-aside contract with an ultimate completion date of August 13, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Feraheme is an intravenous iron replacement...
- The Defense Logistics Agency awarded a delivery order valued at $6,598.26 to AmerisourceBergen Drug Corp for Feraheme 510 mg/17 mL vials on September 4, 2025, with completion scheduled for September 5, 2025. This firm fixed-price delivery order represents a non-set-aside competitive procurement and is being performed at the contractor's facility in Conshohocken, Pennsylvania. Feraheme is an iron replacement therapeutic used in medical treatment, and this delivery order fulfills a specific...
- SPE2DR25D2100Indefinite Delivery Contract
- SPE2DR25D2100-SPE2DR26FA0MCDelivery Order
The Defense Logistics Agency has awarded a $7,783.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Feraheme 510 mg/17 ml vials, with an ultimate completion date of December 9, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime vendor vehicle enables AmerisourceBergen to supply pharmaceutical products and medical supplies to support military healthcare programs globally, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania—the place of performance for this award—is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement. The company maintains an extensive portfolio of delivery orders with DLA covering a broad spectrum of medications and medical supplies across multiple therapeutic domains, demonstrating its capability to fulfill federal healthcare requirements through open competition. This delivery order for Feraheme, an iron replacement therapy, reflects the company's ongoing role in supporting military medicine and veteran healthcare systems through the comprehensive pharmaceutical prime vendor framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.8k | 12/7/25 |